# Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

> **NCT04862858** · NA · UNKNOWN · sponsor: **Humana Inc.** · enrollment: 4197 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Cardiovascular Diseases

## Interventions

- **OTHER:** Educational Intervention

## Key facts

- **NCT ID:** NCT04862858
- **Lead sponsor:** Humana Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-18
- **Primary completion:** 2021-11-30
- **Final completion:** 2022-08-16
- **Target enrollment:** 4197 (ACTUAL)
- **Last updated:** 2022-05-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862858, "Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04862858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*